Patient Management

Schizophrenia continues to challenge researchers due to its complex nature and a lack of coherent understanding, despite extensive studies. Recent efforts to consolidate knowledge about schizophrenia...
CURATED BY: Sarah Ann Scantamburlo,
MSW, MS, PA-C

Patient Management Guidelines

Articles

Danish Study Finds Higher Schizophrenia Risk in Young Males With Cannabis Use Disorder

In a study, researchers focused on the relationship between cannabis use disorder (CUD) and schizophrenia, particularly in males. It was...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Study Urges Inclusive Schizophrenia Research Embracing TGNC Community for Personalized Medicine

Researchers of a recent study highlight the need for including transgender and gender-nonconforming (TGNC) in schizophrenia research, addressing unique challenges...
CURATED BY:
Sarah Ann Scantamburlo,
MSW, MS, PA-C

Schizophrenia Treatments Target Muscarinic Receptors, Promising Personalized Approaches

A study emphasized the importance of muscarinic M1 and M4 receptors in treating schizophrenia, with new medications like KarXT and...
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Emerging Therapies Show Promise for Treating Cognitive Deficits in Schizophrenia, Study Finds

Researchers explored the clinical aspects and causes of cognitive deficits, a core aspect of schizophrenia, examining the roles of dopamine...
CURATED BY:
Sarah Ann Scantamburlo,
MSW, MS, PA-C

Progress in Schizophrenia’s Negative Symptoms Research

Researchers analyzed the evolution of studies on the negative symptoms of schizophrenia from 1966 to 2022 using scientometric methods. The...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Alarming Early Mortality Rates in Schizophrenia-Spectrum Disorder

A study investigated premature mortality in individuals with schizophrenia-spectrum disorder (SSD), particularly during the early stages of the illness. The...
CURATED BY:
Sarah Ann Scantamburlo,
MSW, MS, PA-C
Share